insights_auto
Why is EDIT up 3,97%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,62 $
arrow_upward
+3,97%(+0,100) 1D
2,60 $
arrow_downward
-0,76% (-0,020)bedtimeAfter hours
Closed: 2 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
News stories
From web sources and news partners
The Motley Fool
·
7 րոպե առաջ
The S&P 500 Hasn't Looked This Cheap Based on a Popular Metric in Decades. Should You Buy Stocks Now?
Stock Traders Daily
·
4 ժամ առաջ
(TDIV) Price Dynamics and Execution-Aware Positioning
Simply Wall Street
·
1 ժամ առաջ
3 Consumer Staples Stocks Tied To Rising Pet Care Spending
Business Insider
·
1 օր առաջ
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc